n. a family of peptides produced when
amyloid precursor protein (
APP) is cleaved by certain enzymes. It is produced continuously in healthy brains and normally cleared efficiently, but in
Alzheimer’s disease and sometimes in
Lewy body dementia, it tends to misfold, aggregate, and form extracellular
amyloid plaques, oligomers, and fibrils, contributing to neuronal impairment, neuroinflammation, and eventual neuronal loss. Amyloid-β levels are central biomarkers in the medical diagnosis of Alzheimer’s disease. Also called
beta-amyloid (β-amyloid).